Brokerages Set Addus HomeCare Corporation (NASDAQ:ADUS) Target Price at $131.50

Shares of Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) have been given an average rating of “Moderate Buy” by the eleven ratings firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $131.50.

ADUS has been the topic of a number of recent analyst reports. Citizens Jmp reissued a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Barclays raised their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Finally, Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th.

View Our Latest Analysis on Addus HomeCare

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares of the company’s stock, valued at $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 788 shares of company stock worth $73,506. Company insiders own 4.10% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Large investors have recently modified their holdings of the stock. Global Retirement Partners LLC boosted its holdings in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after buying an additional 186 shares during the period. Larson Financial Group LLC raised its holdings in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares during the period. Acumen Wealth Advisors LLC bought a new position in Addus HomeCare in the 4th quarter valued at about $29,000. Private Trust Co. NA lifted its position in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares during the last quarter. Finally, Arax Advisory Partners lifted its position in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after acquiring an additional 137 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Stock Up 1.1%

NASDAQ:ADUS opened at $116.79 on Thursday. The firm has a market capitalization of $2.18 billion, a price-to-earnings ratio of 21.59, a price-to-earnings-growth ratio of 1.58 and a beta of 0.87. Addus HomeCare has a twelve month low of $87.95 and a twelve month high of $124.43. The stock’s 50 day moving average price is $102.16 and its two-hundred day moving average price is $101.45. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating the consensus estimate of $1.70 by $0.03. The company had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.49 EPS. Equities research analysts expect that Addus HomeCare will post 6.24 earnings per share for the current fiscal year.

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

See Also

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.